Diabetic Foot Ulcer Biologics Market 2030: Growth Factors Accelerate DFU Recovery
The global diabetic foot ulcer biologics market is experiencing strong growth as the prevalence of diabetes and its complications continues to rise across the world. In 2024, the market was estimated at approximately USD 2.01 billion and is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2030 , reaching an estimated USD 3.11 billion by 2030 . This growth is driven by increasing rates of chronic diabetic foot ulcers (DFUs), a growing geriatric population, and ongoing advancements in biologic therapies designed to enhance wound healing. Biologics play a crucial role in managing severe and non-healing wounds by promoting tissue regeneration and reducing infection risks—factors that are critical as healthcare systems globally emphasize early intervention and improved patient outcomes. Multiple demographic and clinical trends are supporting the expansion of this market. As populations age, particularly in developed regions, the incidence of diabetes-re...